Literature DB >> 6104075

Possible risk with captopril in pregnancy: some animal data.

F Broughton Pipkin, S R Turner, E M Symonds.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104075     DOI: 10.1016/s0140-6736(80)91723-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 2.  Renin angiotensin system in development of mice and men.

Authors:  A Fogo; I Ichikawa
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

3.  Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors.

Authors:  B A Baethge; R E Wolf
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

Review 4.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible.

Authors:  A Shrim; H Berger; J Kingdom; A Hamoudi; P S Shah; G Koren
Journal:  Can Fam Physician       Date:  2005-10       Impact factor: 3.275

6.  [Antihypertensive therapy in pregnancy].

Authors:  H Kaulhausen
Journal:  Arch Gynecol       Date:  1986

Review 7.  Aetiology of pre-eclampsia: a review.

Authors:  E M Symonds
Journal:  J R Soc Med       Date:  1980-12       Impact factor: 5.344

Review 8.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 9.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 10.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.